WO2007092713A3 - Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease - Google Patents
Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease Download PDFInfo
- Publication number
- WO2007092713A3 WO2007092713A3 PCT/US2007/061352 US2007061352W WO2007092713A3 WO 2007092713 A3 WO2007092713 A3 WO 2007092713A3 US 2007061352 W US2007061352 W US 2007061352W WO 2007092713 A3 WO2007092713 A3 WO 2007092713A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- detection
- cassette
- precancerous
- cell
- cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0636—Focussing flows, e.g. to laminate flows
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1894—Cooling means; Cryo cooling
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/043—Moving fluids with specific forces or mechanical means specific forces magnetic forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0677—Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Abstract
Biomarkers for the detection of pre-cancer and cancer cells and a method for their detection at the point of care are disclosed. The system is comprised of an inexpensive, disposable microfluidic cassette for sample preparation; continuous-flow, magnetic-bead assisted cell sorting and cytometry; cell lysis; nucleic acid isolation and amplification, hybridization, quantification, and analysis. Typically, the disposable cassette will be used with a benchtop instrument platform that provides power, control and detection capabilities to the cassette. In one particular embodiment and application of the invention, the cell sorting is based on the selective binding of magnetic beads coated with an MCAP antibody to exfoliated precancerous and cancerous cells contained in saliva. The bead-labeled precancerous and cancerous cells are then separated from other saliva components using a magnetic field. Both labeled and unlabeled cells can be counted using integrated detectors of several types, including cell counters based on impedance measurements, and cytometers based on Coulter particle counter principles. The sorted sub-population of precancerous and cancerous cells are lysed, and the nucleic acids are isolated for gene assays and/or transcription profiling of the sorted sample subpopulation. In one embodiment of the invention, the cassette includes re verse- transcription polymerase chain reaction for nucleic acid detection and a hybridization array for gene identification. The devices, systems, modes of operation, and methods disclosed here are also applicable for cancer and other disease detection in other body fluids.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76439006P | 2006-02-02 | 2006-02-02 | |
US60/764,390 | 2006-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007092713A2 WO2007092713A2 (en) | 2007-08-16 |
WO2007092713A3 true WO2007092713A3 (en) | 2008-12-18 |
Family
ID=38345869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/061352 WO2007092713A2 (en) | 2006-02-02 | 2007-01-31 | Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007092713A2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US9216412B2 (en) | 2009-11-23 | 2015-12-22 | Cyvek, Inc. | Microfluidic devices and methods of manufacture and use |
US9229001B2 (en) | 2009-11-23 | 2016-01-05 | Cyvek, Inc. | Method and apparatus for performing assays |
US9500645B2 (en) | 2009-11-23 | 2016-11-22 | Cyvek, Inc. | Micro-tube particles for microfluidic assays and methods of manufacture |
US9546932B2 (en) | 2009-11-23 | 2017-01-17 | Cyvek, Inc. | Microfluidic assay operating system and methods of use |
CN108485912A (en) * | 2018-03-27 | 2018-09-04 | 上海默礼生物医药科技有限公司 | A kind of miniature more warehouses control nucleic acid detection apparatus |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004047953A1 (en) * | 2004-10-01 | 2006-04-20 | Rudolf Rigler | Selection of particle possessing predetermined property from population encompassing multiplicity of different particles, comprises providing population of different particles, and labeling particles which possess predetermined property |
NZ564141A (en) | 2005-05-09 | 2011-02-25 | Theranos Inc | Two way communication system for monitoring an analyte |
US11287421B2 (en) | 2006-03-24 | 2022-03-29 | Labrador Diagnostics Llc | Systems and methods of sample processing and fluid control in a fluidic system |
US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US7807454B2 (en) | 2006-10-18 | 2010-10-05 | The Regents Of The University Of California | Microfluidic magnetophoretic device and methods for using the same |
US20100151465A1 (en) | 2008-03-27 | 2010-06-17 | Jingyue Ju | Selective Capture and Release of Analytes |
EP3181228B1 (en) | 2007-10-02 | 2020-07-29 | Labrador Diagnostics LLC | Modular point-of-care devices and uses thereof |
DE102007062441A1 (en) | 2007-12-20 | 2009-06-25 | Aj Innuscreen Gmbh | Mobile rapid test system for nucleic acid analysis |
WO2009082242A2 (en) * | 2007-12-21 | 2009-07-02 | University Of Otago | Optical analyte detection incorporating a micromirror device |
DE102008009920A1 (en) * | 2008-02-15 | 2009-08-20 | Aj Innuscreen Gmbh | Mobile device for nucleic acid isolation |
US9090663B2 (en) | 2009-04-21 | 2015-07-28 | The Trustees Of Columbia University In The City Of New York | Systems and methods for the capture and separation of microparticles |
AU2010239154A1 (en) * | 2009-04-22 | 2011-11-10 | Clinical Genomics Pty. Ltd. | Method and apparatus for isolating a target bioentity from a biological sample |
DE102009043426B4 (en) * | 2009-09-29 | 2012-05-24 | Siemens Aktiengesellschaft | Apparatus and method for obtaining, detecting and analyzing cells in a microfluidic system |
DE102009043537B4 (en) | 2009-09-30 | 2012-03-22 | Siemens Aktiengesellschaft | Method and device for determining cell vitalities |
GB2474306A (en) * | 2009-10-12 | 2011-04-13 | Bioproducts Ltd | Methods and device for detecting an analyte |
MX2012004620A (en) | 2009-10-19 | 2012-06-25 | Theranos Inc | Integrated health data capture and analysis system. |
GB0919159D0 (en) * | 2009-11-02 | 2009-12-16 | Sec Dep For Environment Food A | Device and apparatus |
US10022696B2 (en) | 2009-11-23 | 2018-07-17 | Cyvek, Inc. | Microfluidic assay systems employing micro-particles and methods of manufacture |
US9855735B2 (en) | 2009-11-23 | 2018-01-02 | Cyvek, Inc. | Portable microfluidic assay devices and methods of manufacture and use |
US10065403B2 (en) | 2009-11-23 | 2018-09-04 | Cyvek, Inc. | Microfluidic assay assemblies and methods of manufacture |
US9700889B2 (en) | 2009-11-23 | 2017-07-11 | Cyvek, Inc. | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results |
US9759718B2 (en) | 2009-11-23 | 2017-09-12 | Cyvek, Inc. | PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use |
EE201000013A (en) * | 2010-01-29 | 2011-10-17 | Selfdiagnostics O� | Method and rapid assay device for detecting target rk molecule from sample material |
BR112013018656B1 (en) | 2011-01-21 | 2021-03-02 | Labrador Diagnostics Llc | method for detecting the presence or concentration of an analyte in a sample of fluid contained in a container, and, method of measuring the concentration of analyte in a sample of fluid |
WO2012115926A2 (en) * | 2011-02-21 | 2012-08-30 | Rheonix, Inc. | Microfluidic device-based nucleic acid purification method |
WO2013019714A1 (en) | 2011-07-29 | 2013-02-07 | The Trustees Of Columbia University In The City Of New York | Mems affinity sensor for continuous monitoring of analytes |
WO2013067272A1 (en) * | 2011-11-04 | 2013-05-10 | Diagnostics For All, Inc. | Low cost, disposable molecular diagnostic devices |
US9617589B2 (en) | 2012-05-25 | 2017-04-11 | The University Of North Carolina At Chapel Hill | Microfluidic devices, solid supports for reagents and related methods |
DK2864781T3 (en) * | 2012-06-22 | 2018-02-05 | Scandinavian Micro Biodevices Aps | A METHOD AND SYSTEM FOR QUANTITATIVE OR QUALITATIVE DETERMINATION OF A TARGET COMPONENT |
EP2796876A1 (en) * | 2013-04-25 | 2014-10-29 | Hasenkam ApS | Strip for monitoring analyte concentrations |
CN103267860B (en) * | 2013-05-22 | 2015-04-29 | 上海市第十人民医院 | Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing kit for diagnosing jawbone carcinoma |
CN103308694A (en) * | 2013-05-22 | 2013-09-18 | 苏州市马尔泰新材料有限公司 | Gold-labeled kit for salivary gland carcinoma diagnosis |
CN103293296A (en) * | 2013-05-22 | 2013-09-11 | 苏州市马尔泰新材料有限公司 | Application of cysteine-rich secretory protein 1 (CRISP 1) in preparation of kit for diagnosing carcinoma of floor of mouth |
CN103293319A (en) * | 2013-05-22 | 2013-09-11 | 苏州市马尔泰新材料有限公司 | Gold-labeled test paper for rapidly diagnosing carcinoma jaw |
CN103257238B (en) * | 2013-05-22 | 2015-01-28 | 上海市第十人民医院 | Application of CRISP (cysteine-rich secretory protein)1 test paper for diagnosing carcinoma of maxillary sinus |
CN103267848A (en) * | 2013-05-22 | 2013-08-28 | 苏州市马尔泰新材料有限公司 | CRISP1 (cystein-rich secretory protein 1) kit for quickly diagnosing gingival carcinoma |
CN103308682A (en) * | 2013-05-22 | 2013-09-18 | 苏州市马尔泰新材料有限公司 | Kit for rapid lip cancer diagnosis |
CN103257228A (en) * | 2013-05-22 | 2013-08-21 | 苏州市马尔泰新材料有限公司 | Novel application of CRISP1 (cysteine-rich secretory protein 1) kit for diagnosis on carcinoma of palate |
CN103267857A (en) * | 2013-05-22 | 2013-08-28 | 苏州市马尔泰新材料有限公司 | CRISP1 (cystein-rich secretory protein 1) test paper for diagnosing tongue cancer |
CN103278645B (en) * | 2013-05-22 | 2015-01-28 | 上海市第十人民医院 | Application of gold-labelled test strip for quickly diagnosing carcinoma of lip |
CN103267858B (en) * | 2013-05-22 | 2015-03-25 | 上海市第十人民医院 | Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing gold label test paper for diagnosing salivary gland carcinoma |
CN103257240B (en) * | 2013-05-22 | 2015-03-25 | 上海市第十人民医院 | Application of CRISP (cysteine-rich secretory protein)1 kit for diagnosing carcinoma of tongue |
CN103278646B (en) * | 2013-05-22 | 2015-01-28 | 上海市第十人民医院 | Application of gold-labelled cysteine-rich secretory protein (CRISP)1 kit for diagnosing mouth floor carcinoma |
CN103267856B (en) * | 2013-05-22 | 2015-04-29 | 上海市第十人民医院 | Application of kit for diagnosing jaw cancer |
CN103293320B (en) * | 2013-05-22 | 2015-03-25 | 上海市第十人民医院 | Application of cysteine-rich secretory protein 1 (CRISP 1) in preparation of gingival cancer diagnosis products |
CN103267859B (en) * | 2013-05-22 | 2015-03-11 | 上海市第十人民医院 | Application of CRISP1 (cystein-rich secretory protein 1) test paper for diagnosing gingival carcinoma |
CN103257242B (en) * | 2013-05-22 | 2015-01-28 | 上海市第十人民医院 | Application of CRISP (cysteine-rich secretory protein)1 kit for diagnosing carcinoma of buccal mucosa |
CN103257241B (en) * | 2013-05-22 | 2015-04-29 | 上海市第十人民医院 | New application of CRISP (cysteine-rich secretory protein)1 to medical instrument |
CN103267861B (en) * | 2013-05-22 | 2015-01-14 | 上海市第十人民医院 | Application of cysteine-rich secretory protein 1 in manufacturing product for diagnosing palate carcinoma |
CN103257239A (en) * | 2013-05-22 | 2013-08-21 | 苏州市马尔泰新材料有限公司 | Application of kit for quickly diagnosing carcinoma of salivary gland |
CN103278644A (en) * | 2013-05-22 | 2013-09-04 | 苏州市马尔泰新材料有限公司 | Gold-labelled CRISP (cysteine-rich secretory protein)1 kit for quickly diagnosing carcinoma of palate |
CN103308692A (en) * | 2013-05-22 | 2013-09-18 | 苏州市马尔泰新材料有限公司 | CRISP1 (Cysteine-Rich Secretory Protein 1) gold-labeled kit for rapid oral floor carcinoma diagnosis |
CN103308691B (en) * | 2013-05-22 | 2015-04-29 | 上海市第十人民医院 | Application of secretory protein 1 rich in cysteine in preparation of product for diagnosing cheilocarcinoma |
CN103267863A (en) * | 2013-05-22 | 2013-08-28 | 苏州市马尔泰新材料有限公司 | CRISP1 (cystein-rich secretory protein 1) test paper for quickly diagnosing carcinoma of maxillary sinus |
CN103308693A (en) * | 2013-05-22 | 2013-09-18 | 苏州市马尔泰新材料有限公司 | Application of secretory protein 1 rich in cysteine in medical apparatus |
CN103267864A (en) * | 2013-05-22 | 2013-08-28 | 苏州市马尔泰新材料有限公司 | Application of kit for diagnosing oropharyngeal cancer |
CN103308695A (en) * | 2013-05-22 | 2013-09-18 | 苏州市马尔泰新材料有限公司 | Cysteine-rich secretory protein 1 (CRISP1) kit for cheek carcinoma diagnosis |
CN103278629A (en) * | 2013-05-22 | 2013-09-04 | 苏州市马尔泰新材料有限公司 | Gold-labelled kit for quickly diagnosing oropharynx carcinoma |
CN103267862A (en) * | 2013-05-22 | 2013-08-28 | 苏州市马尔泰新材料有限公司 | Application of CRISP1 (Cysteine-Rich Secretory Protein 1) in preparing gold label kit for diagnosing maxillary sinus carcinoma |
CN103411981B (en) * | 2013-07-25 | 2016-06-22 | 宁波大学 | One utilizes dielectric and magnetic characteristic to differentiate the epithelioglandular method of gastric cancer |
FR3009082B1 (en) | 2013-07-26 | 2016-10-21 | Centre Nat Rech Scient | MICROFLUIDIC SYSTEM AND METHOD FOR ISOLATING AND QUANTIFYING AT LEAST ONE SUB-POPULATION OF CELLS FROM A POPULATION OF CELLS |
US11318479B2 (en) | 2013-12-18 | 2022-05-03 | Berkeley Lights, Inc. | Capturing specific nucleic acid materials from individual biological cells in a micro-fluidic device |
WO2016022696A1 (en) | 2014-08-05 | 2016-02-11 | The Trustees Of Columbia University In The City Of New York | Method of isolating aptamers for minimal residual disease detection |
KR101702745B1 (en) * | 2014-11-13 | 2017-02-03 | 인제대학교 산학협력단 | Apparatus and method for separating single cell |
EP3314183B1 (en) * | 2015-07-22 | 2020-09-02 | The University of North Carolina at Chapel Hill | Fluidic devices with freeze-thaw valves with ice-nucleating agents and related methods of operation and analysis |
WO2017065854A2 (en) | 2015-07-22 | 2017-04-20 | The University Of North Carolina At Chapel Hill | Fluidic devices with bead well geometries with spatially separated bead retention and signal detection segments and related methods |
CN115532189A (en) | 2015-11-23 | 2022-12-30 | 伯克利之光生命科技公司 | In-situ generated microfluidic isolation structure, kit and use method thereof |
US10228367B2 (en) | 2015-12-01 | 2019-03-12 | ProteinSimple | Segmented multi-use automated assay cartridge |
TWI758265B (en) | 2015-12-08 | 2022-03-21 | 美商伯克利之光生命科技公司 | In situ-generated microfluidic assay structures, related kits, and methods of use thereof |
JP6902548B2 (en) | 2016-01-15 | 2021-07-14 | バークレー ライツ,インコーポレイテッド | Manufacturing method of patient-specific anticancer therapeutic agent and its therapeutic method |
US11097272B2 (en) | 2016-07-26 | 2021-08-24 | Hewlett-Packard Development Company, L.P. | Microfluidic apparatuses for fluid movement control |
KR102560201B1 (en) * | 2016-10-23 | 2023-07-27 | 버클리 라잇츠, 인크. | Methods for screening B cell lymphocytes |
EP3609619A1 (en) * | 2017-04-14 | 2020-02-19 | University Of Twente | Device and method for the continuous trapping of circulating tumor cells |
EP3758718A4 (en) * | 2018-03-01 | 2021-11-10 | Academia Sinica | Devices and methods for detecting cancerous cells |
KR102401909B1 (en) * | 2018-08-30 | 2022-05-24 | 주식회사 엘지화학 | A high-speed screening analysis system for reaction optimization |
WO2020068069A1 (en) * | 2018-09-26 | 2020-04-02 | Hewlett-Packard Development Company, L.P. | Dielectrophoresis and density separators |
WO2021234729A1 (en) * | 2020-05-16 | 2021-11-25 | Indian Institute Of Science Education And Research (Iiser) Kolkata | Laser induced micro-bubble based patterning of biological macromolecules towards bio-sensing applications |
CN111944656B (en) * | 2020-07-06 | 2022-07-29 | 东南大学 | Microfluidic cell magnetic capture and detection system and capture and detection method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013645A (en) * | 1987-04-14 | 1991-05-07 | Abbott Laboratories | Immunological methods and materials for detection of tumor associated antigens |
US6074827A (en) * | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
US6103537A (en) * | 1997-10-02 | 2000-08-15 | Aclara Biosciences, Inc. | Capillary assays involving separation of free and bound species |
US6268219B1 (en) * | 1999-07-09 | 2001-07-31 | Orchid Biosciences, Inc. | Method and apparatus for distributing fluid in a microfluidic device |
US6355491B1 (en) * | 1999-03-15 | 2002-03-12 | Aviva Biosciences | Individually addressable micro-electromagnetic unit array chips |
-
2007
- 2007-01-31 WO PCT/US2007/061352 patent/WO2007092713A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013645A (en) * | 1987-04-14 | 1991-05-07 | Abbott Laboratories | Immunological methods and materials for detection of tumor associated antigens |
US6074827A (en) * | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
US6103537A (en) * | 1997-10-02 | 2000-08-15 | Aclara Biosciences, Inc. | Capillary assays involving separation of free and bound species |
US6355491B1 (en) * | 1999-03-15 | 2002-03-12 | Aviva Biosciences | Individually addressable micro-electromagnetic unit array chips |
US6268219B1 (en) * | 1999-07-09 | 2001-07-31 | Orchid Biosciences, Inc. | Method and apparatus for distributing fluid in a microfluidic device |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9216412B2 (en) | 2009-11-23 | 2015-12-22 | Cyvek, Inc. | Microfluidic devices and methods of manufacture and use |
US9229001B2 (en) | 2009-11-23 | 2016-01-05 | Cyvek, Inc. | Method and apparatus for performing assays |
US9500645B2 (en) | 2009-11-23 | 2016-11-22 | Cyvek, Inc. | Micro-tube particles for microfluidic assays and methods of manufacture |
US9546932B2 (en) | 2009-11-23 | 2017-01-17 | Cyvek, Inc. | Microfluidic assay operating system and methods of use |
CN108485912A (en) * | 2018-03-27 | 2018-09-04 | 上海默礼生物医药科技有限公司 | A kind of miniature more warehouses control nucleic acid detection apparatus |
CN108485912B (en) * | 2018-03-27 | 2021-05-07 | 上海默礼生物医药科技有限公司 | Miniature many storehouses control nucleic acid detection device |
Also Published As
Publication number | Publication date |
---|---|
WO2007092713A2 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007092713A3 (en) | Microfluidic system and method for analysis of gene expression in cell-containing samples and detection of disease | |
Wu et al. | Single-cell protein analysis | |
Zhang et al. | Microfluidic systems for rapid antibiotic susceptibility tests (ASTs) at the single-cell level | |
Clayton et al. | Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017 | |
KR102243597B1 (en) | Selective delivery of material to cells | |
Gascoyne et al. | Microfluidic approaches to malaria detection | |
Ying et al. | Microfluidic chip-based technologies: emerging platforms for cancer diagnosis | |
WO2009051734A1 (en) | Microchip-based devices for capturing circulating tumor cells and methods of their use | |
WO2021170009A1 (en) | Fetal cell capture module and microfluidic chip for fetal cell capture and methods for using the same | |
WO2020043036A1 (en) | Co-detection and digital quantification of bioassay | |
CN111500769A (en) | Fluorescence immunochromatography method for detecting SARS-CoV-2 nucleic acid | |
Di Carlo et al. | Introduction: why analyze single cells? | |
Pensold et al. | Methods for single-cell isolation and preparation | |
Chen et al. | Microfluidic methods for cell separation and subsequent analysis | |
Huang et al. | Isolation of circulating fetal trophoblasts by a four-stage inertial microfluidic device for single-cell analysis and noninvasive prenatal testing | |
Suzuki et al. | Mechanical low-pass filtering of cells for detection of circulating tumor cells in whole blood | |
Jeon et al. | Fully automated, sample-to-answer leukocyte functional assessment platform for continuous sepsis monitoring via microliters of blood | |
Inci et al. | Bio-inspired magnetic beads for isolation of sperm from heterogenous samples in forensic applications | |
Jiao et al. | Recent advances in microfluidic single-cell analysis and its applications in drug development | |
Wang et al. | Sickle-like inertial microfluidic system for online rare cell separation and tandem label-free quantitative proteomics (Orcs-Proteomics) | |
US20160258938A1 (en) | Method of detecting an analyte in a sample | |
Xiao et al. | A rapid, simple, and low-cost CD4 cell count sensor based on blocking immunochromatographic strip system | |
Schröder et al. | Immuno-PCR with digital readout | |
WO2019079334A1 (en) | Disease proteome protein arrays and uses thereof | |
Ho et al. | Quantification techniques for circulating tumor cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07763203 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07763203 Country of ref document: EP Kind code of ref document: A2 |